Cost Effectiveness of Pramipexole in Parkinson??s Disease in the US
- 1 January 1998
- journal article
- research article
- Published by Springer Nature in PharmacoEconomics
- Vol. 14 (5) , 541-557
- https://doi.org/10.2165/00019053-199814050-00006
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- The Impact of Parkinson??s Disease on Health Status, Health Expenditures, and ProductivityPharmacoEconomics, 1997
- Combination Antiretroviral Therapy in HIV InfectionPharmacoEconomics, 1996
- Cost Effectiveness of Thrombolytic Therapy with Tissue Plasminogen Activator as Compared with Streptokinase for Acute Myocardial InfarctionNew England Journal of Medicine, 1995
- A multicenter double‐blind placebo‐controlled trial of pergolide as an adjunct to sinemet® in Parkinson's diseaseMovement Disorders, 1994
- Effects of Tocopherol and Deprenyl on the Progression of Disability in Early Parkinson's DiseaseNew England Journal of Medicine, 1993
- Early combination therapy with bromocriptine and levodopa in parkinson's diseaseMovement Disorders, 1993
- Predicting Nursing-Home Admission and Length of StayMedical Care, 1991
- Effect of Deprenyl on the Progression of Disability in Early Parkinson's DiseaseNew England Journal of Medicine, 1989
- Double-Blind Controlled Study of Pergolide Mesylate in the Treatment of Parkinsonʼs DiseaseClinical Neuropharmacology, 1987
- ParkinsonismNeurology, 1967